The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The treatment of malignant pheochromocytoma with Iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Scintigraphic Localization of Pheochromocytoma
Sisson, J. C., Frager, M. S., Valk, T. W., Gross, M. D., Swanson, D. P., Wieland, D. M., Tobes, M. C., Beierwaltes, W. H., & Thompson, N. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050103 · Cited by 544
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Pheochromocytoma: current status and changing trends.
van Heerden, J. A., Sheps, S. G., Hamberger, B., Sheedy, P. F., Poston, J. G., & ReMine, W. H. (1982) · PubMed · Cited by 233
Radiopharmaceutical treatment of malignant pheochromocytoma.
Sisson, J. C., Shapiro, B., Wh, B., Glowniak, J. V., Nakajo, M., Mangner, T. J., Je, C., Dp, S., Copp, J., & SATTERLEE, W. G. (1984) · PubMed · Cited by 219
Schlumberger, M. J., Gicquel, C., Lumbroso, J., Tenenbaum, F., Comoy, E., Bosq, J., Fonseca, E., Ghillani‐Dalbin, P., Aubert, B., Travagli, J. P., et al. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03345807 · Cited by 156
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi, F. A., Shapiro, B., Fig, L. M., Mallette, S., & Sisson, J. C. (1989) · PubMed · Cited by 141
Error and corrections with scintigraphic measurement of gastric emptying of solid foods.
Meyer, J. H., VanDeventer, G., Graham, L., Thomson, J., & Thomasson, D. M. (1983) · PubMed · Cited by 117
Treatment of malignant pheochromocytoma with combination chemotherapy.
Keiser, H. R., Goldstein, D. S., Wade, J. L., Douglas, F. L., & Averbuch, S. D. (1985) · Hypertension · doi:10.1161/01.hyp.7.3_pt_2.i18 · Cited by 104
Use ofm-[131I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., CARPENTIER, P., Fleury-Goyon, M. C., Gibold, C., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-455 · Cited by 91
Clinical experience with malignant pheochromocytomas.
Scott, H. W., Reynolds, V., Green, N., Page, D. L., Oates, J. A., Robertson, D., & Roberts, S. (1982) · PubMed · Cited by 91
Malignant pheochromocytoma: A series of 14 cases observed between 1966 and 1990
Mornex, R., Badet, C., & Peyrin, L. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03345808 · Cited by 79
No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs, R. J., Cunningham, S. H., Russell, J., Armour, A., Owens, J., McKellar, K. A. J., & Gaze, M. N. (1995) · PubMed · Cited by 48
Bomanji, J. B., Britton, K. E., Ur, E., Hawkins, L., Grossman, A. B., & BESSER, G. M. (1993) · Nuclear Medicine Communications · doi:10.1097/00006231-199310000-00004 · Cited by 45
Mairs, R., Russell, J., Cunningham, S., O’Donoghue, J. A., Gaze, M. N., Owens, J. E., Vaidyanathan, G., & Zalutsky, M. R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00052-k · Cited by 41
Pujol, P., Bringer, J., Faurous, P., et al. (1995) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00941856 · Cited by 23
131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma
Sakahara, H., Endo, K., Saga, T., Hosono, M., Kobayashi, H., & Konishi, J. (1994) · Annals of Nuclear Medicine · doi:10.1007/bf03165018 · Cited by 22
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., Carpentier, P., Fleury-Goyon, M. C., & Gibold, C. (1991) · PubMed · Cited by 22
Lewi, H., Reid, R., Mucci, B., Davidson, J., KYLE, K. F., MACPHERSON, S. G., SEMPLE, P. F., & Kaye, S. L. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb06295.x · Cited by 21
Sasaki, M., Iwaoka, T., Yamauchi, J., TOKUNAGA, H., Naomi, S., Inoue, J., Oishi, S., UMEDA, T., & Sato, T. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.155 · Cited by 19
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
Lewington, V. J., Ma, Z., Tristam, M., Aj, M., & Dm, A. (1991) · PubMed · Cited by 19
[131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
Ca, H., Schornagel, J. H., & Olmos, V. S. (1991) · PubMed · Cited by 19
[131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
Troncone, L., Rufini, V., Ms, D., De Santis, M., & Luzi, S. (1991) · PubMed · Cited by 17
Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
Fischer, M. (1991) · PubMed · Cited by 15
Colombo, L., Lomuscio, G., Vignati, A., & Dottorini, M. E. (1991) · PubMed · Cited by 10
Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
Bestagno, M., Pizzocaro, C., Maira, G., Terzi, A. C., Panarotto, M. B., & Guerra, P. (1991) · PubMed · Cited by 9
Schvartz, C., Gibold, C., Vuillemin, B., & Mj, D. (1991) · PubMed · Cited by 6
Cited by
Therapeutic Radiopharmaceuticals
Volkert, W. A., & Hoffman, T. J. (1999) · Chemical Reviews · doi:10.1021/cr9804386 · Cited by 724
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A.-P., Grossman, A. B., Kimura, N., Mannelli, M., McNicol, A. M., & Tischler, A. S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0396 · Cited by 680
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Personalized Management of Pheochromocytoma and Paraganglioma
Nölting, S., Bechmann, N., Taieb, D., Beuschlein, F., Fassnacht, M., Kroiss, M., Eisenhofer, G., Grossman, A., & Pacak, K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab019 · Cited by 417
Eisenhofer, G. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 342
Metadata
- Authors
- Loh, K.-C., Fitzgerald, P. A., Matthay, K. K., Yeo, P. P. B., & Price, D. C.
- Venue
- Journal of Endocrinological Investigation
- Published
- 1997-12
- Volume
- 20
- Issue
- 11
- Pages
- 648-658
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2095058352
- Cited by
- 278
- References
- 27
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.